医学类个人简历(2)

 
从新产品研发到上市的推进协调 （新事业发展（NBD）部）
      l Promotion and co-ordination of new product in the stages from their research and development to launching them onto the market; (the New Business Development Division)
 
    
 
2000 - 2002年    上海○○○○科技有限公司   总经理 （个人公司）
2000 - 2002       Had acted as the general manager of Shanghai      Technology Co. Ltd. (an individual-owned company)
 
进口药品添加剂的国内销售  技术支持  财会等全面管理
      l In charge of overall management affairs of selling the imported medicinal additives on the home market, handle the technical support jobs and those in the finance division. 
 
 
 
1996 - 1999年    日本著名大公司  药品及食品添加剂部   中国市场经理
1996 - 1999        Had been a Chinese Marketing Manager of Medicine and Food Additives Division of a famous big-sized Japanese company.
 
药品相关法规及市场调研  市场策略  工作目标及计划  
      l Research of medicine-related regulation and study of marketing affairs, as well as responsible for marketing strategy and scheming of work objectives and plans.
 
为公司主要产品进入中国市场进行药品进口注册  
      l Conduct registry work for company’s major product being exported into Chinese market.
 
策划 实施大型产品发布会  行业展览  产品演示等市场拓展活动
      l Scheme and conduct market development activities of big-sized product release show, exhibition within the trade, and product roadshows etc.
 
构筑全国范围内同大学院校  科研机构的技术合作交流网络
      l Had Built a technical cooperation network with some colleges and universities all over the nation and with a few technical research institutions.
 
协调由产品进口-代理商-用户的产品流通各个环节
      l Had coordinated in various stages of product circulation from their importation to the distribution dealers, and finally to the customers.
 
产品销售  技术支持（如速崩、控释制剂等药品固体制剂新技术）
      l In charge of product sale and technical support (for new technology on solid medicines such as those for curing frusemide, dediabetes insipidus and for controlling urine release.
 
 
 
1993 - 1994年    日本神户学院大学药剂研究室  访问交流学者
1993 - 1994       Had been a visiting scholar at Pharmaceutical Research Institute of Kobe Gakuin University, Japan
 
抗过敏新药的药物代谢动力学评价
      l Had Engaged in the dynamic appraisals of drug metabolism of the new anti-allergic drugs.